BACKGROUND: Spitzoid melanocytic lesions represent a heterogeneous group of proliferations with ambiguous and overlapping terminology. The exact distinction of a Spitz nevus from a Spitzoid melanoma can be very difficult or, in some cases, impossible. Among the Spitzoid lesions, there is a lesion termed an atypical Spitz tumour (AST) that has intermediate histopathologic features between those of a Spitz nevus and a Spitzoid melanoma and thus uncertain malignant potential. There are several rare cases of patients with a Spitzoid melanoma initially misdiagnosed as a Spitz nevus or an AST with fatal consequences. It is, therefore, advised to perform a molecular characterization in cases where uncertain skin lesions are presented, as it may provide extended set of information with a possible impact on the treatment options. Furthermore, preventive measures, such as regular physical and skin examinations, as well as thorough scheduling of individual follow-up visits, are essential in patients with potentially malignant skin nevi. CASE REPORT: We report a case of a young adult female with a history of AST excision with a negative sentinel lymph node biopsy (SLNB) and insufficient follow-up. Four years after the primary dermatological diagnosis, she presented with a giant tumour in the right hemithorax. Radical en bloc resection of the tumour with right pneumonectomy and resection of the pericardium with reconstruction of the pericardium using mesh was performed. A definitive histopathological examination revealed a metastatic melanoma. The association of the previously diagnosed AST and subsequent appearance of melanoma metastases led to a retrospective re-evaluation of the initial lesion. The suspected diagnosis of Spitzoid melanoma, however, was not confirmed. Moreover, the molecular examination revealed a major discordance between the initial lesion and the lung tumour, which most likely excluded the possible association of the lung metastasis with the initial skin lesion. The initial skin lesion was a BRAF-mutant melanoma with Spitzoid features and termed as AST, while the giant lung metastasis was NRAS-mutant melanoma. The subsequent postoperative course was complicated by the appearance of brain metastases that were stereotactically irradiated. Nevertheless, despite complex specialised medical care, the patient's clinical condition rapidly deteriorated. By this time, no active oncological treatment was possible. The patient was delegated to local hospice for palliative care six months after the surgery and died three weeks later. CONCLUSIONS: Our patient was surgically treated at the age of 20 for AST and died four years later of metastatic NRAS-mutant melanoma most likely of different occult origin. Molecular characterization, as well as the close clinical follow-up should be always precisely performed in patients with uncertain skin lesions, such as AST.

3rd Department of Surgery 1st Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Immunology 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Pathology and Molecular Medicine 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Department of Respiratory Medicine Palacký University Medical School and Teaching Hospital Olomouc Czech Republic

Department of Transcription and Cell Signaling Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Spitz S. Melanomas of childhood. Am J Pathol. 1948;24(3):591. PubMed PMC

Luo S, Sepehr A, Tsao H. Spitz nevi and other Spitzoid lesions: Part I. Background and Diagnoses. J Am Acad Dermatol. 2011;65(6):1073–1084. doi: 10.1016/j.jaad.2011.04.040. PubMed DOI PMC

Moscarella E, Lallas A, Kyrgidis A, et al. Clinical and dermoscopic features of atypical Spitz tumors: a multicenter, retrospective, case-control study. J Am Acad Dermatol. 2015;73(5):777–784. doi: 10.1016/j.jaad.2015.08.018. PubMed DOI PMC

Kim JY, Choi JE, Ahn HH, et al. A case of spitzoid melanoma with lymph node metastasis in a child. J Korean Med Sci. 2012;27(4):454–457. doi: 10.3346/jkms.2012.27.4.454. PubMed DOI PMC

Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999;30(5):513–520. doi: 10.1016/S0046-8177(99)90193-4. PubMed DOI

Cho-Vega JH. A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment. Mod Pathol. 2016;29(7):656. doi: 10.1038/modpathol.2016.70. PubMed DOI

Van Dijk MCF, Bernsen MR, Ruiter DJ. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. The American journal of surgical pathology. 2005;29(9):1145–1151. doi: 10.1097/01.pas.0000157749.18591.9e. PubMed DOI

Lee DA, Cohen JA, Twaddell WS, et al. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma. Cancer. 2006;106(4):907–913. doi: 10.1002/cncr.21686. PubMed DOI

Cho-Vega JH. A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment. Mod Pathol. 2006;29(7):656–670. doi: 10.1038/modpathol.2016.70. PubMed DOI

Ludgate MW, Fullen DR, Lee J, et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2009;115(3):631–641. doi: 10.1002/cncr.24047. PubMed DOI

Massi D, De Giorgi V, Mandalà M. The complex management of atypical Spitz tumours. Pathology. 2016;48(2):132–141. doi: 10.1016/j.pathol.2015.12.003. PubMed DOI

Duncan LM. Atypical Spitz tumours and sentinel lymph nodes. Lancet Oncol. 2014;15(4):377–378. doi: 10.1016/S1470-2045(13)70397-8. PubMed DOI

Raghavan SS, Peternel S, Mully TW, et al. Spitz melanoma is a distinct subset of spitzoid melanoma. Modern Pathology. 2020;33:1122–34. PubMed PMC

Hillen LM, Van den Oord J, Geybels MS, et al. Genomic landscape of Spitzoid neoplasms impacting patient management. Frontiers in medicine. 2018;5:344. doi: 10.3389/fmed.2018.00344. PubMed DOI PMC

Pellegrini C, Cardelli L, Padova MD, et al. Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases. Acta Dermato-Venereologica. 2020;100(1–2):1–8. doi: 10.2340/00015555-3382. PubMed DOI PMC

Wiesner T, Murali R, Fried I, et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. The American journal of surgical pathology. 2012;36(6):818. doi: 10.1097/PAS.0b013e3182498be5. PubMed DOI PMC

Yang C, Sanchez-Vega F, Chang JC, et al. Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma. Modern Pathology. 2020;33:2244–55. PubMed PMC

Hibiya T, Tanaka M, Matsumura M, et al. An NRAS mutation in primary malignant melanoma of the lung: a case report. Diagnostic Pathology. 2020;15(1):11. doi: 10.1186/s13000-020-0928-8. PubMed DOI PMC